Saba Capital Management, L.P. bought HQL
June 26, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 100 shares of Abrdn Life Sciences Investors at $14.07 per share, a transaction worth $1.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
100
Price
$14.07
Total value
$1.4K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 26, 2024
Filing dateJune 27, 2024
Shares owned after3,429,991
OwnershipIndirect
10b5-1 planNo
AmendedNo